Cargando…
Monte Carlo simulation of the Spearman-Kaerber TCID50
BACKGROUND: In the biological sciences the TCID50 (median tissue culture infective dose) assay is often used to determine the strength of a virus. METHODS: When the so-called Spearman-Kaerber calculation is used, the ratio between the pfu (the number of plaque forming units, the effective number of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331834/ https://www.ncbi.nlm.nih.gov/pubmed/22330733 http://dx.doi.org/10.1186/2043-9113-2-5 |
_version_ | 1782230152058503168 |
---|---|
author | Wulff, Niels H Tzatzaris, Maria Young, Philip J |
author_facet | Wulff, Niels H Tzatzaris, Maria Young, Philip J |
author_sort | Wulff, Niels H |
collection | PubMed |
description | BACKGROUND: In the biological sciences the TCID50 (median tissue culture infective dose) assay is often used to determine the strength of a virus. METHODS: When the so-called Spearman-Kaerber calculation is used, the ratio between the pfu (the number of plaque forming units, the effective number of virus particles) and the TCID50, theoretically approaches a simple function of Eulers constant. Further, the standard deviation of the logarithm of the TCID50 approaches a simple function of the dilution factor and the number of wells used for determining the ratios in the assay. However, these theoretical calculations assume that the dilutions of the assay are independent, and in practice this is not completely correct. The assay was simulated using Monte Carlo techniques. RESULTS: Our simulation studies show that the theoretical results actually hold true for practical implementations of the assay. Furthermore, the simulation studies show that the distribution of the (the log of) TCID50, although discrete in nature, has a close relationship to the normal distribution. CONCLUSION: The pfu is proportional to the TCID50 titre with a factor of about 0.56 when using the Spearman-Kaerber calculation method. The normal distribution can be used for statistical inferences and ANOVA on the (the log of) TCID50 values is meaningful with group sizes of 5 and above. |
format | Online Article Text |
id | pubmed-3331834 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33318342012-04-23 Monte Carlo simulation of the Spearman-Kaerber TCID50 Wulff, Niels H Tzatzaris, Maria Young, Philip J J Clin Bioinforma Research BACKGROUND: In the biological sciences the TCID50 (median tissue culture infective dose) assay is often used to determine the strength of a virus. METHODS: When the so-called Spearman-Kaerber calculation is used, the ratio between the pfu (the number of plaque forming units, the effective number of virus particles) and the TCID50, theoretically approaches a simple function of Eulers constant. Further, the standard deviation of the logarithm of the TCID50 approaches a simple function of the dilution factor and the number of wells used for determining the ratios in the assay. However, these theoretical calculations assume that the dilutions of the assay are independent, and in practice this is not completely correct. The assay was simulated using Monte Carlo techniques. RESULTS: Our simulation studies show that the theoretical results actually hold true for practical implementations of the assay. Furthermore, the simulation studies show that the distribution of the (the log of) TCID50, although discrete in nature, has a close relationship to the normal distribution. CONCLUSION: The pfu is proportional to the TCID50 titre with a factor of about 0.56 when using the Spearman-Kaerber calculation method. The normal distribution can be used for statistical inferences and ANOVA on the (the log of) TCID50 values is meaningful with group sizes of 5 and above. BioMed Central 2012-02-13 /pmc/articles/PMC3331834/ /pubmed/22330733 http://dx.doi.org/10.1186/2043-9113-2-5 Text en Copyright ©2012 Wulff et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Wulff, Niels H Tzatzaris, Maria Young, Philip J Monte Carlo simulation of the Spearman-Kaerber TCID50 |
title | Monte Carlo simulation of the Spearman-Kaerber TCID50 |
title_full | Monte Carlo simulation of the Spearman-Kaerber TCID50 |
title_fullStr | Monte Carlo simulation of the Spearman-Kaerber TCID50 |
title_full_unstemmed | Monte Carlo simulation of the Spearman-Kaerber TCID50 |
title_short | Monte Carlo simulation of the Spearman-Kaerber TCID50 |
title_sort | monte carlo simulation of the spearman-kaerber tcid50 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3331834/ https://www.ncbi.nlm.nih.gov/pubmed/22330733 http://dx.doi.org/10.1186/2043-9113-2-5 |
work_keys_str_mv | AT wulffnielsh montecarlosimulationofthespearmankaerbertcid50 AT tzatzarismaria montecarlosimulationofthespearmankaerbertcid50 AT youngphilipj montecarlosimulationofthespearmankaerbertcid50 |